SAVA Cassava Sciences Stock Price

Cassava Pharma - graphic logo of issuer SAVA

Global demand for Alzheimer's therapy remains colossal, and the success of Cassava Sciences, Inc. (SAVA) depends on the regulatory verdict. Currently, Cassava Sciences, Inc. (SAVA) relies on investment capital to conduct clinical trials for brain regeneration, while the 2.39 indicator persists. The market capitalization trend on GURU.Markets confirms that drug approval would create powerful demand inertia and ensure monopoly profits for decades.

Cassava Pharma - SAVA Price Chart (period 07/04/2022 - 03/11/2026)

Cassava (SAVA) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Analysis of all company metrics:cassavasciences.com SAVA
Signature product of Cassava Sciences Inc

The market value of the share reflects investors' aggregate valuation of future cash flows, which depend directly on operational success in drug development. This indicator captures the daily value of the business stake, which for Cassava Sciences, Inc. (SAVA) is determined by the effectiveness of researchers working on Alzheimer's therapy, as clearly evidenced by the asset's price action.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|VKTX (Viking Pharma) - Stock Quotes|Share Price SUPN|Price Chart Catalyst Pharmaceuticals|Share Price DNLI (Denali Therapeutics Inc)|Stock Price HRMY|BHVN - Market Price|amylyx.com - Stock Quotes|Stock Price Trevi Therapeutics Inc TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex Life Sciences Corp)|CeriBell Inc (CBLL) - Price Chart|Market Price Prothena Corp (PRTA)|ALEC (Alector Therapeutics) - Stock Price|Stock Price Annexon Biosciences|Price Chart Omeros Corp (OMER)|NGNE - Market Price|AC Immune - Stock Quotes|Voyager Therapeutics (VYGR) - Market Price|NMRA - Price Chart|SCLX: Price Chart|TVGN: Stock Price|Alpha Cognition (ACOG) - Stock Price|Stock Quotes CGTX|Stock Price Inhibikase Therapeutics|Stock Price ASRT|COYA (Coya Therapeutics) - Price Performance Chart|Price Chart vistagen.com VTGN|Ovid Therapeutics Inc. (OVID) - Market Price|Acumen Pharmaceuticals - Stock Price|Price Performance Chart CRVO (CervoMed Inc.)|ATHE (alteritytherapeutics.com) - Stock Quotes|CLNN - Market Chart|Stock Quotes PEPG|Stock Price jupiterneurosciences.com|Price Chart Relmada Therapeutics (RLMD)|ANVS (Annovis Bio, Inc.) - Price Performance Chart|Stock Price GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Market Price|Klotho Neurosciences - Stock Price|Market Price NeuroSense Therapeutics Ltd.|RVPH: Stock Price|MetaVia, Inc. (MTVA) - Stock Price|Stock Quotes NRXS|Helius Medical (HSDT) - Market Chart|Price Chart passagebio.com (PASG)|NEUP - Market Price|Price Chart Minerva Neurosciences, Inc. NERV|Market Chart Athira Pharma, Inc. (ATHA)|addextherapeutics.com - Stock Price|Market Chart alzamend.com ALZN|CYCN: Stock Price|PTIX: Price|Price Chart Pasithea Therapeutics Corp.|Stock Price cortigent.com|Stock Quotes ATXI (Avenue Therapeutics, Inc)|Stock Price Brainstorm Cell Therapeutics Inc. (BCLI)|Stock Price CARA (Cara Therapeutics Inc)|Market Chart Chromocell Therapeutics Corporation (CHRO)|Eliem - Stock Price|Market Chart intracellulartherapies.com ITCI|Longboard Pharmaceuticals Inc (LBPH) - Price Chart|Marinus Pharmaceuticals Inc - Price Performance Chart|Price Chart NKGen|Price Chart NRBO|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel